
### [NCIT:C88890](http://purl.obolibrary.org/obo/NCIT_C88890)
**Label:** Stage III Lung Cancer AJCC v7

**Subclasses:** [NCIT:C8766](http://purl.obolibrary.org/obo/NCIT_C8766) (Stage III Squamous Cell Lung Carcinoma AJCC v7), [NCIT:C7778](http://purl.obolibrary.org/obo/NCIT_C7778) (Stage III Non-Small Cell Lung Cancer AJCC v7), [NCIT:C9257](http://purl.obolibrary.org/obo/NCIT_C9257) (Stage III Large Cell Lung Carcinoma AJCC v7), [NCIT:C8751](http://purl.obolibrary.org/obo/NCIT_C8751) (Stage III Adenosquamous Lung Carcinoma AJCC v7), [NCIT:C8761](http://purl.obolibrary.org/obo/NCIT_C8761) (Stage III Lung Adenocarcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 53.33%
- [NCIT:C27970](http://purl.obolibrary.org/obo/NCIT_C27970) (Stage III) 53.33%
- Thing 53.10%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40379](http://purl.obolibrary.org/obo/NCIT_C40379) (Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40363](http://purl.obolibrary.org/obo/NCIT_C40363) (Nipple Syringomatous Adenoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40362](http://purl.obolibrary.org/obo/NCIT_C40362) (Low Grade Adenosquamous Breast Carcinoma))) 38.69%


